After 12 years on the board of the International Society of Radiology (ISR), it is with complex feelings I have entered the last stage as the organization’s immediate past president. On one hand, it is relaxing to know that new and powerful forces have taken over. On the other, it is a little bit sad to know that there was a lot left to do, issues that I should have fixed-or at least tackled to start a resolving process.
After 12 years on the board of the International Society of Radiology (ISR), it is with complex feelings I have entered the last stage as the organization’s immediate past president. On one hand, it is relaxing to know that new and powerful forces have taken over. On the other, it is a little bit sad to know that there was a lot left to do, issues that I should have fixed-or at least tackled to start a resolving process.
The transfer of the presidential chain of ISR takes place during the biannual International Congress of Radiology. This year ICR took place in Shanghai, for the second time in China. The first was in Beijing in 1996. The congress facilities in Shanghai were spectacular, located at the mouth of the Yangtze River in the expanding, modern, Pudong part of the city. We were surrounded by a whole new high-rise center with ultramodern architecture. The Shanghai International Convention Center is seen from the water in the picture below as the low building with globes on each side.
There was a practical complication, as the World Fair would open in less than a month and the government had decided two weeks before the congress that some of the exposition space was needed for the fair. Program committee chair Professor Xiaoyuan Feng, however, handled the situation in a splendid way and was able to accommodate the 75 scientific and 25 commercial exhibits with maximum exposure for the participants, in open spaces between lecture halls.
At ICR 2010, Prof. Nicholas Gourtsoyiannis (right), the new President of the ISR, signed a co-operation agreement with Prof. Michel Claudon, President of the World Federation for Ultrasound in Medicine and Biology.
The educational program was of very high quality and virtually all major regional radiological societies presented their own symposia and other programs. A total of about 250 speakers from all around the world filled the program in six lecture halls during four days. As a speaker, I can certify that the full audience, mostly from China, was very eager and a lot of discussion about the most recent developments of all possible radiological modalities took place.
The International Committee of ISR met during the congress, with representation from a large number of national radiological societies. One task of this committee is to elect the national representation on the ISR board for 2010 to 2012. After a lot of interest and lobbying, Brazil, China, France, Spain, and the RSNA won the election. The ISR executive committee also decided that the next ICR will take place in São Paulo, Brazil, May 3 to 6, 2012.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.